# GoodRx Expands Offerings to Now Include Ozempic® Pill for Type 2 Diabetes Patients
Canonical URL: https://biopharmsignal.com/news/GDRX/goodrx-expands-offerings-to-now-include-ozempicr-pill-for-type-2-diabetes-patients
Ticker: GDRX
Company: GoodRx
Source: GoodRx
Published: 2026-05-01 12:10 EST
Original Source URL: https://investors.goodrx.com
## Summary

Eligible self-pay patients can access the oral diabetes treatment for as low as $149 per month Brief Summary: GoodRx expands access to Ozempic® pill (oral semaglutide) for as low as $149 per month Available at GoodRx’s nationwide pharmacy network Adds an oral option to the Ozempic treatment

## Article Body
Eligible self-pay patients can access the oral diabetes treatment for as low as $149 per month Brief Summary: GoodRx expands access to Ozempic® pill (oral semaglutide) for as low as $149 per month Available at GoodRx’s nationwide pharmacy network Adds an oral option to the Ozempic treatment
## Recent Company News
- 2026-05-27 13:00 EST — [GoodRx Launches GoodRx Companion, a New Subscription Designed to Lower Everyday Healthcare Costs](https://biopharmsignal.com/news/GDRX/goodrx-launches-goodrx-companion-a-new-subscription-designed-to-lower-everyday-healthcare-costs) — Source: GoodRx
- 2026-05-06 20:05 EST — [GoodRx Reports First Quarter 2026 Results](https://biopharmsignal.com/news/GDRX/goodrx-reports-first-quarter-2026-results) — Source: GoodRx
- 2026-05-01 12:10 EST — [GoodRx Expands Offerings to Now Include Ozempic® Pill for Type 2 Diabetes Patients](https://biopharmsignal.com/news/GDRX/goodrx-expands-offerings-to-now-include-ozempicr-pill-for-type-2-diabetes-patients) — Source: GoodRx
- 2026-04-17 20:05 EST — [GoodRx Announces Date for First Quarter 2026 Earnings Release and Conference Call](https://biopharmsignal.com/news/GDRX/goodrx-announces-date-for-first-quarter-2026-earnings-release-and-conference-call) — Source: GoodRx
- 2026-04-15 13:00 EST — [GoodRx Now Offers Access to Wegovy® HD at $399 Per Month Self-Pay Price](https://biopharmsignal.com/news/GDRX/goodrx-now-offers-access-to-wegovyr-hd-at-399-per-month-self-pay-price) — Source: GoodRx
## Related News
- 2026-07-21 20:15 EST — BFRG — [BullFrog AI to Participate in Water Tower Research Fireside Chat on Thursday, July 23, 2026](https://biopharmsignal.com/news/BFRG/bullfrog-ai-to-participate-in-water-tower-research-fireside-chat-on-thursday-jul-78357ce8)
- 2026-07-21 20:05 EST — CLPT — [ClearPoint Neuro to Announce Second Quarter 2026 Results August 3, 2026](https://biopharmsignal.com/news/CLPT/clearpoint-neuro-to-announce-second-quarter-2026-results-august-3-2026-6e4f3c05)
- 2026-07-21 20:05 EST — TCMD — [Tactile Medical to Release Second Quarter of Fiscal Year 2026 Financial Results on August 10, 2026](https://biopharmsignal.com/news/TCMD/tactile-medical-to-release-second-quarter-of-fiscal-year-2026-financial-results--798d4004)
- 2026-07-21 20:05 EST — PIII — [P3 Health Partners Schedules Second Quarter 2026 Earnings Release and Conference Call](https://biopharmsignal.com/news/PIII/p3-health-partners-schedules-second-quarter-2026-earnings-release-and-conference-6c9bd8a7)
- 2026-07-21 12:05 EST — VRCA — [Verrica Pharmaceuticals and Medomie Pharma Enter into Exclusive Distribution, Marketing and Supply Agreement to Commercialize YCANTH® for the Treatment of Molluscum Contagiosum in Israel](https://biopharmsignal.com/news/VRCA/verrica-pharmaceuticals-and-medomie-pharma-enter-into-exclusive-distribution-mar-abf61522)